Sorrento Therapeutics Inc (SRNE): Pfizer's antiviral sales are over $2...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	57
Posts	5700
Boards Moderated	0
Alias Born	12/13/2004

dia76ca

Re: Jesspro post# 14147

Monday, 10/17/2022 6:56:01 PM

Monday, October 17, 2022 6:56:01 PM

Pfizer's antiviral sales are over $22 Billion this year.
If Sorrento's Mpro drug is safer, better and cheaper than their antiviral might Pfizer want to buy it?
If Sorrento sells the Mpro drug to Pfizer what do we expect?
If the sales are some $20 Billion a year ... can we expect at least $60 Billion? More?
What would they pay for Mpro, ABIVERTINIB and Semdexa package? Or the entire company? Hmmm!

"The refusal of the real is the number one dogma of our time" Rene Girard

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM